Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status
1Chair of Oncology, Poland
2Departments of Gynecology and Obstetrics, Holy Family Clime, Poland
3Chair of Radiology and Biology Faculty of Medicine, K.Marcinkowski University School of Medicine, Poznan, Poland
*Corresponding Author(s): J. Markowska E-mail:
In women with CIN at fertile age and those over 50 years of age, EGFR expression is lower in the presence of Chlamydia trachomatis (Cht) infection. In all Cht infected women over 50 years of age expression of Ki 67 is higher; the increase is significant among women with invasive carcinoma. In these groups of women with CIN and invasive carcinoma TGF-alpha expression is insignificantly augmented. Chronic Cht infection is associated with cervical hypertrophy.
Cht infection; CIN; Cervical cancer; Hormonal status
J. Markowska,N. Fischer,Z. Fischer,J.B. Warchol. Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status. European Journal of Gynaecological Oncology. 2002. 23(6);511-513.
[1] Anttila T., Saikku P., Koskela P., et al.: "Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma". J.A.M.A., 2000, 285, 47.
[2] Beatty W. L., Morrison R. P., Byrne G. L.: "Persistent Chlamydiae". Microbial. Rev., 1994, 58, 686.
[3] Blum H., Benaim J.: "Activities of a family planning chmc rncorporated to a public medical service over a 4-year period". Rev. Fr. Gynecol. Obstet., 1991, 86 (5), 381.
[4] Bose S. K., Goswami P. C.: "Enhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment of HeLa cells". Inject. Immun., 1986, 53 (3), 646.
[5] Koivisto A. L., lsoacho R., von Hertzen L., et al.: "Chlamydial antibodies in an elderly Finnish population". Scand. J. Infect. Dis., 1999, 31 (2), 135.
[6] Koskela P., Anttila T., Bjiirge T., et al.: "Chlamydia trachomatis infection as a risk for invasive cervical carcinoma". Int. J. Cancer, 2000, 85, 35.
[7] Markowska J., Fischer N., Filas V., et al.: "The role of Chlamydia trachomatis infection in cervical cancer development". Eur. J. Gynaecol. Oneal., 1999, 20 (2), 144.
[8] Puolakkainen M., Vesterinen E., Purola E., et al.: "Persistence of chlamydia] antibodies after pelvic inflammatory disease". J. Clin Microbial., 1986, 23, 924.
[9] Suchet H.: "Hormonal contraception and pelvic inflammatory disease". Ew: J. Contracept. Reprod. Health Care, 1997, 4, 267.
[10] Wallin K. L., Wiklund F., Angstrom T., et al.:'Type-specific persistence of human papilloma virus DNA before the development of invasive cervical cancer". N. Engl. J. Med., 1999, 341, 1633.
[11] Zdrodowska Stefanow B., Ostaszewska J.: "Chlamydia trachomatis- infections in humans (in Polish)", 2000.
[12] Zur Hausen H.: "Cervical carcinoma and human papilloma virus: on the road to preventing a major human cancer". J. Natl. Cancer Inst., 2001, 93 (4), 252.
Web of Science (WOS) (On Hold)
Journal Citation Reports/Science Edition
Google Scholar
JournalSeek
Top